NCT04731376View on ClinicalTrials.gov

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
HypogonadismMalignant Urinary System NeoplasmUrinary System DisorderUrinary System Neoplasm
Interventions
OTHER

Best Practice

Receive standard peri-operative care

PROCEDURE

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies; Quality of life questionnaires will be given both preoperatively and at 3-months postoperatively

DRUG

Testosterone Cypionate

Given IM

Trial Locations (1)

30322

RECRUITING

Emory University Hospital/Winship Cancer Institute, Atlanta

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER